Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS)
Condition(s):Amyotrophic Lateral SclerosisLast Updated:December 30, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Amyotrophic Lateral SclerosisLast Updated:December 30, 2015Completed
Condition(s):Secondary-progressive Multiple SclerosisLast Updated:July 12, 2021Completed
Condition(s):Parkinson DiseaseLast Updated:September 14, 2017Unknown status
Condition(s):Progressive Multiple SclerosisLast Updated:September 5, 2021Completed
Condition(s):Obesity, MorbidLast Updated:December 16, 2020Terminated
Condition(s):Parkinson’s Disease; ParkinsonismLast Updated:April 12, 2022Withdrawn
Condition(s):Ischaemic Stroke; Cerebral Infarction; Hemiparesis; Arm ParalysisLast Updated:July 23, 2018Completed
Condition(s):Peripheral Arterial DiseaseLast Updated:January 31, 2018Completed
Condition(s):Ischemic Motor Stroke, ChronicLast Updated:October 5, 2017Unknown status
Condition(s):Cervical Spinal Cord Injury; Spine Injury; Cervical Spine InjuryLast Updated:June 2, 2016Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.